血浆ACE2浓度与死亡及心血管代谢疾病风险:病例队列分析
ACE2是死亡的强预测因子,并超越部分传统危险因素对心衰、卒中和心梗的预测。
要点
- 血浆ACE2每升高1 SD,总死亡风险增加35%,心血管与非心血管死亡风险相似。
- ACE2是死亡的最高排名预测因子,对心衰、卒中和心梗的预测超越部分传统危险因素。
核心结论
- 在全球研究中,血浆ACE2浓度升高与主要心血管事件风险增加相关。
主要发现
- 上述关联独立于年龄、性别、族裔和传统心脏危险因素;除心衰外,调整BNP后ACE2与死亡等终点的独立关系仍稳健。
- ACE2浓度的最高排名决定因素为性别、地理族裔和体重指数(BMI)。
- 与临床危险因素(吸烟、糖尿病、血压、血脂、BMI)相比,ACE2是死亡的最高排名预测因子,并超越部分危险因素对心衰、卒中和心梗的预测。
临床怎么用
- 血浆ACE2可作为死亡及心血管代谢事件的风险分层标志物,但需进一步验证后用于临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-regulator of the renin-angiotensin hormonal cascade. We assessed whether plasma ACE2 concentrations were associated with greater risk of death or cardiovascular disease events. METHODS: We used data from the Prospective Urban Rural Epidemiology (PURE) prospective study to conduct a case-cohort analysis within a subset of PURE participants (from 14 countries across five continents: Africa, Asia, Europe, North America, and South America). We measured plasma concentrations of ACE2 and assessed potential determinants of plasma ACE2 levels as well as the association of ACE2 with cardiovascular events. FINDINGS: We included 10 753 PURE participants in our study. Increased concentration of plasma ACE2 was associated with increased risk of total deaths (hazard ratio [HR] 1·35 per 1 SD increase [95% CI 1·29-1·43]) with similar increases in cardiovascular and non-cardiovascular deaths. Plasma ACE2 concentration was also associated with higher risk of incident heart failure (HR 1·27 per 1 SD increase [1·10-1·46]), myocardial infarction (HR 1·23 per 1 SD increase [1·13-1·33]), stroke (HR 1·21 per 1 SD increase [1·10-1·32]) and diabetes (HR 1·44 per 1 SD increase [1·36-1·52]). These findings were independent of age, sex, ancestry, and traditional cardiac risk factors. With the exception of incident heart failure events, the independent relationship of ACE2 with the clinical endpoints, including death, remained robust after adjustment for BNP. The highest-ranked determinants of ACE2 concentrations were sex, geographic ancestry, and body-mass index (BMI). When compared with clinical risk factors (smoking, diabetes, blood pressure, lipids, and BMI), ACE2 was the highest ranked predictor of death, and superseded several risk factors as a predictor of heart failure, stroke, and myocardial infarction. INTERPRETATION: Increased plasma ACE2 concentration was associated with increased risk of major cardiovascular events in a global study. FUNDING: Canadian Institute of Health Research, Heart & Stroke Foundation of Canada, and Bayer.
引用
- Narula S, Yusuf S, Chong M, et al. Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis. Lancet. 2020. PMID: 33010842. doi:10.1016/S0140-6736(20)31964-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。